Neutron Production in The Scattering S250 Mevion Proton-Therapy System

Nima Tatari
DOI: https://doi.org/10.48550/arXiv.2210.12602
2022-11-15
Abstract:Secondary radiation in a radiation therapy environment is considered a cause for post-treatment side effects including secondary carcinogenesis. In a proton-therapy setup, neutrons deliver a considerable extra dose to the patient. Various measurements and calculations of neutron dose suggest a wide range of values for this quantity. This paper provides a comparison between the previously published values and analyzes the Monte Carlo calculated neutron dose from the present work using the neutron cross-section data. The purpose is to provide a range for the convergence of several neutron-absorbed dose data points (e.g. 3.94 mSv/Gy in a Bonner sphere measurement and 0.4 mSv/Gy in a SWENDI measurement) in previous works of other authors.
Medical Physics
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the impact of secondary neutron radiation on the additional dose to patients during treatment in the Mevion passive - scattering proton therapy system. Specifically, the paper focuses on how to calculate the neutron dose generated under different conditions through Monte Carlo simulation and compare it with previous research results to evaluate the contribution of neutrons from different sources to the total absorbed dose. The main purpose of the paper is to provide a range in which multiple neutron absorbed dose data points can converge, such as 3.94 mSv/Gy obtained by Bonner sphere measurement in previous studies and 0.4 mSv/Gy obtained by SWENDI measurement. ### Purpose of the paper - **Evaluating secondary neutron radiation**: Evaluate the impact of secondary neutron radiation generated during proton therapy on the additional dose to patients. - **Data convergence**: Compare the neutron dose calculated by Monte Carlo simulation with the measured values in previous studies to determine whether these data points can converge within a reasonable range. - **Analyzing neutron sources**: Analyze the contribution of different components (such as nozzles, scatterers, collimators, etc.) to neutron generation and absorbed dose. ### Methods - **Monte Carlo simulation**: Use the Geant4 toolkit to perform Monte Carlo simulation of particle transport and calculate the neutron flux spectra at different energies. - **Geometric modeling**: Simulate the geometric structures of the treatment room, synchrocyclotron, nozzle components, and water phantom (simulating the human body). - **Data comparison**: Compare the simulation results with previous experimental measurement data to verify the accuracy of the simulation. ### Results - **Neutron flux spectra**: The neutron flux spectra generated by different components are obtained by simulation and compared with previous experimental data. - **Dose distribution**: Analyze the neutron absorbed dose distribution at different positions (along the beam direction and parallel to the beam direction). - **Contribution analysis**: Analyze in detail the contribution of each component to the total absorbed dose, especially the proportion of internally - generated neutrons and externally - generated neutrons. ### Conclusions - **Data consistency**: The neutron dose calculated by simulation is consistent with the previous measured values within an error range of 1%, further verifying the accuracy of the Extended - Range Bonner Sphere (ERBS) measurement method. - **Neutron sources**: The study shows that the proportion of externally - generated neutrons in the total absorbed dose is less than 50%, which means that this part of the dose can be reduced by optimizing the treatment equipment design. - **Dose distribution characteristics**: The neutron dose distribution at different positions shows a specific pattern, especially when the water phantom is present or absent, the change in neutron dose is significant. ### Keywords - Proton therapy - Mevion - Secondary radiation - Neutron absorbed dose Through these studies, the paper provides important reference data and theoretical support for neutron dose control during proton therapy.